F17L (p.Phe17Leu) variant of BEST1 (Bestrophin-1)

F17L (p.Phe17Leu) in BEST1 (Bestrophin-1) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.71 / 1. The record also includes population frequency data and structural context.

F17L (p.Phe17Leu) variant details